NIAGEN BIOSCIENCE, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, other for the quarter ending 2011-12-31 was $0.00.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, other for the quarter ending 2011-10-01 was $1.52M.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, other for the quarter ending 2011-07-02 was $528.00K.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, other for the quarter ending 2011-04-02 was $480.00K.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, other for fiscal 2011 was $2.52M, a 111.83% increase from fiscal 2011.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, other for fiscal 2011 was $1.19M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2012-03-15 | $2.52M 10-K · filed 2012-03-15 |
| 2011-10-01 | $1.52M 10-Q · filed 2011-11-10 | |
| 2011-07-02 | $528.00K 10-Q · filed 2011-11-10 | |
| 2011-04-02 | $480.00K 10-Q · filed 2011-11-10 | |
| 2011-01-01 | $1.19M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |